Fierce Biotech June 5, 2024
It’s all systems go for Moon Surgical with a new FDA green light for its Maestro robotic laparoscopy platform.
The company said it will now begin deploying its surgical assistant in the U.S. through a limited rollout—while also expanding its reach in Europe, where it received a CE mark approval in September 2023. The countdown for a broader commercial launch will extend into 2025.
Maestro aims to help surgeons by providing two flexible arms that can be used to hold minimally invasive instruments and cameras in place during a procedure. The robotic appendages can be manipulated by hand and paired with nearly any off-the-shelf laparoscopic tool.
“Our Maestro System introduces a new category of robotic surgery tailored for the broad...
Today's Sponsors
Today's Sponsor